Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Results 41 - 50 of 223 for bayer. (0.13 seconds)

Cancer Drug Reaches Surrogate Endpoint. More details...
CBT 200 Gains 28 Points. More details...
CBT 200 Scores A Win. More details...
Will It Buy Onyx Next?. More details...
CBT 220 Slips 19 Points Lower. More details...
CBT 220 Slips 19 Points Lower. More details...
CBT 200 Gets Positive For 2006. More details...
Nexavar Revenues Beat Estimates. More details...
Joinn Laboratories, a pre-clinical CRO with facilities in...
WuXi Biologics signed a long-term lease for a German...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital